Sen. Peter Welch

Maddy summaryThis bill amends the Older Americans Act to add new home modification services for older individuals (60+). It directly affects older adults by authorizing: (1) air-quality improvements like ventilation upgrades and reducing indoor pollutants from gas appliances; (2) energy-efficient home modifications prioritizing low-emission technologies; and (3) assistance with utility costs through existing programs. The key mechanism expands eligibility to include multi-family dwellings, rental units, and homes occupied by older individuals living with non-older residents. These provisions aim to improve indoor air quality, reduce energy costs, and lower emissions without creating new federal programs.

Maddy summaryThis bill reauthorizes the Patrick Leahy Lake Champlain Basin Program Foundation to protect and restore Lake Champlain and its watershed, which includes parts of New York and Vermont (and potentially Quebec). It establishes a Steering Committee with representatives from New York, Vermont, and Quebec to develop and implement a comprehensive plan for pollution prevention, ecosystem restoration, and climate change response. The bill authorizes $45 million annually from 2025-2034 to fund the Foundation's work, which will support projects to improve water quality, restore habitats, and address climate impacts in the Lake Champlain Basin. The Foundation will coordinate with federal, state, and local partners to carry out the plan, which must include public input and be reviewed every 5 years.

Maddy summaryThe Stop Corporate Capture Act requires agencies to disclose conflicts of interest when reviewing studies submitted by interested parties, including corporations, industry groups, or advocacy organizations. It mandates that agencies make these studies publicly available and consider social equity impacts in rulemaking decisions. The bill establishes an Office of the Public Advocate to improve public participation in the regulatory process and conduct social equity assessments. It also includes penalties for submitting false information to agencies and requires agencies to explain why they withdraw proposed rules. These provisions aim to increase transparency and reduce undue corporate influence in regulatory decision-making.

Maddy summaryThe Agency Stability Restoration Act of 2024 amends two federal laws to clarify the timeframe for challenging agency decisions in court. It adds a 6-year statute of limitations for lawsuits under Section 702 of Title 5 (which governs judicial review of agency actions), requiring such cases to be filed within 6 years of the final agency decision. This change affects individuals, businesses, or organizations seeking to legally contest federal agency actions. The bill does not alter substantive agency powers but standardizes the deadline for judicial review under existing law.

Maddy summaryThis bill requires lenders using the Uniform Residential Loan Application to add a specific disclaimer below the military service question: "If yes, you may qualify for a VA Home Loan. Consult your lender regarding eligibility." It directly affects military service members and veterans applying for home loans, aiming to increase awareness of VA loan eligibility. The bill mandates this change within six months of enactment and requires a GAO study within 18 months to assess whether at least 80% of lenders include the disclaimer on the form.

Maddy summaryThe Affordable Prescriptions for Patients Act of 2023 targets "product hopping" by pharmaceutical manufacturers, which occurs when companies discontinue an original drug to make way for a follow-on product and prevent competition from cheaper generics or biosimilars. The bill prohibits two types of anti-competitive conduct: "hard switches" (discontinuing a drug or withdrawing approval) and "soft switches" (taking actions to disadvantage the original drug relative to a follow-on product). It gives the Federal Trade Commission authority to enforce these rules, including seeking remedies like disgorgement of profits from anti-competitive behavior. This legislation directly affects drug manufacturers, particularly those producing reference drugs and follow-on products, with the goal of increasing competition in the pharmaceutical market and lowering prescription costs.

Maddy summarySRES 765 is a Senate resolution honoring the late Senator James M. Inhofe of Oklahoma following his death on July 9, 2024. The resolution commemorates his 28-year Senate service (1994-2023) and 52 years in public office, highlighting his work on defense policy, aviation legislation, infrastructure projects, and support for military bases in Oklahoma. This procedural resolution expresses the Senate's condolences and formally recognizes his legacy, rather than enacting any policy changes.

Maddy summaryThe "Promoting a Resolution to the Tibet-China Dispute Act" amends the Tibetan Policy Act of 2002 to clarify US policy regarding Tibet. It directs the US Special Coordinator for Tibetan Issues to counter Chinese disinformation about Tibet's history, culture, and institutions, including claims that Tibet has been part of China since ancient times. The bill specifically defines Tibetan Autonomous Regions for policy purposes and authorizes funds to support these counter-disinformation efforts. It reaffirms that Tibet has a distinct cultural identity and that dialogue between China and Tibetan representatives should occur without preconditions. The bill does not change US diplomatic relations with China but provides specific guidance for US policy implementation.

Maddy summarySRES 763 is a symbolic Senate resolution designating July 2024 as "Plastic Pollution Action Month." It does not create new laws or regulations but formally recognizes the environmental and health impacts of plastic pollution - citing statistics on global plastic production, low recycling rates, ocean contamination, and human microplastic exposure. The resolution encourages all U.S. individuals to voluntarily reduce plastic use, participate in cleanup efforts, and support reuse initiatives during July 2024 and year-round. It serves as a non-binding awareness tool, referencing existing public efforts like Plastics Free July and the International Coastal Cleanup. This resolution directly affects the public by promoting voluntary action, not by imposing legal requirements.

Maddy summaryThe Capping Prescription Costs Act of 2024 sets a yearly limit on out-of-pocket costs for prescription drugs under most health insurance plans. Starting in 2026, individual plan members would pay no more than $2,000 annually for covered drugs, while families would pay no more than $4,000. These limits would increase each year based on inflation, adjusted using the medical care component of the Consumer Price Index. The bill applies to both individual health plans and employer-sponsored group plans covered under the Affordable Care Act. It takes effect for plans beginning after December 2025.